Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis

Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis 多聚嘧啶区结合蛋白1(PTBP1)在选择性剪接、糖酵解和肿瘤发生中的作用 first-author corresp ‡Corresponding Author ‡Corresponding Author †E-mail:rencaiping@csu.edu.cn †E-mail:rencaiping@csu.edu.cn rencaiping@csu.edu.cn NHC Key Laboratory of Carcinogenesis (Central South University) and the Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, China NHC Key Laboratory of Carcinogenesis (Central South University) and the Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, China Polypyrimidine tract-binding protein 1 (PTBP1) plays an essential role in splicing and is expressed in almost all cell types in humans, unlike the other proteins of the PTBP family. PTBP1 mediates several cellular processes in certain types of cells, including the growth and differentiation of neuronal cells and activation of immune cells. Its function is regulated by various molecules, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA-binding proteins. PTBP1 plays roles in various diseases, particularly in some cancers, including colorectal cancer, renal cell cancer, breast cancer, and glioma. In cancers, it acts mainly as a regulator of glycolysis, apoptosis, proliferation, tumorigenesis, invasion, and migration. The role of PTBP1 in cancer has become a popular research topic in recent years, and this research has contributed greatly to the formulation of a useful therapeutic strategy for cancer. In this review, we summarize recent findings related to PTBP1 and discuss how it regulates the development of cancer cells. 多聚嘧啶区结合蛋白1(PTBP1)在多种疾病,尤其是在某些癌症中发挥作用.为明确PTBP1在人体的生物学功能,本文汇总了调控PTBP1相关的miRNA、长链非编码RNA(lncRNA)和RNA结合蛋白.另外,我们重点阐述了PTBP1充当糖酵解、细胞凋亡、增殖、肿瘤发生、侵袭和迁移的调节剂,并为制定有用的癌症治疗策略做出了潜在贡献. Polypyrimidine tract-binding protein 1 (PTBP1) Alternative splicing Glycolysis M2 isoform of pyruvate kinase (PKM2) Cancer 多聚嘧啶区结合蛋白1(PTBP1) 选择性剪接 糖酵解 丙酮酸激酶M2亚型(PKM2) 癌症 Introduction 1 Polypyrimidine tract-binding protein (PTBP) preferentially binds to polypyrimidine-rich stretches of RNA. It functions mainly in splicing, and can shuttle between the cytoplasm and the nucleus. PTBP1 belongs to the PTB family, which also includes PTBP2 and PTBP3. PTBP1 is expressed in nearly all cell types, PTBP2 is expressed exclusively in the nervous system, and PTBP3 is found predominantly in immune cells (Ghetti et al., 1992 1992 ; Wagner et al., 1999 1999 ). These three paralogs share more than 70% sequence homology at the protein level, and all contain four RNA recognition motifs (RRMs) that are used to bind RNA (Oberstrass et al., 2005 2005 ). PTBP1 is a known regulator of posttranscriptional gene expression that controls messenger RNA (mRNA) splicing, translation, stability, and localization. It has numerous molecular functions related to RNA metabolism and is a major repressive regulator of alternative splicing, causing exon skipping in many alternatively spliced precursor mRNAs (pre-mRNAs) (Takahashi et al., 2015 2015 ). Alternative splicing is a regulated process that results in multiple mRNAs and proteins encoded from a single gene. During gene expression, particular exons of the gene can be included or excluded from the final processed mRNA (Black, 2003 2003 ). Abnormal alternative splicing leads to splicing variants and contributes to the development of cancer (Sveen et al., 2016 2016 ). PTBP1 has been shown to play roles in modulating splice-site selection and functions as an alternative splicing regulator in mammalian cells (Busch and Hertel, 2012 2012 ). It crosslinks to the pyrimidine tracts within 3' splice sites and represses exon selection, preventing the exon from splicing (Xue et al., 2009 2009 ; Llorian et al., 2010 2010 ). When PTBP1 binds to exonic or/and flanking intronic sequences around the alternative exon, it promotes the inclusion of alternative exons (Corrionero and Valcarcel, 2009 2009 ; Fu and Ares, 2014 2014 ). PTBP1 influences pre-mRNA processing and is associated with pre-mRNAs. It is also related to mRNA transport and metabolism (Han et al., 2014 2014 ). PTBP1 participates in many kinds of activities in different cells, such as the growth and differentiation of neuronal cells, activation of T cells, spermatogenesis, embryonic development, and erythrocyte development. Among its activities in all kinds of cells, the role that PTBP1 plays in the growth and differentiation of neuronal cells is the most important. PTBP1 functions in the entire progression of neuronal cells, including the neuronal transcriptional program, neurogenesis, synapse maturation, and differentiation (Yap et al., 2012 2012 ; Zheng et al., 2012 2012 ; Linares et al., 2015 2015 ). In cancer cells, glycolysis is the most important process in which PTBP1 is involved (Shinohara et al., 2016 2016 ). PTBP1 promotes the expression of M2 isoform of pyruvate kinase (PKM2) and decreases the expression of PKM1, which leads mainly to a metabolic shift from oxidative phosphorylation to glycolysis in cancer cells and affects tumorigenesis (He et al., 2014 2014 ). Apoptosis, proliferation, migration, and invasion are also regulated by PTBP1 via different pathways and molecules (Cui and Placzek, 2016 2016 ; Jo et al., 2017 2017 ). It is widely reported that colorectal cancer and glioma are the most common types of cancer involving PTBP1 (Cheung et al., 2009 2009 ; Takahashi et al., 2015 2015 ; Zhang et al., 2018 2018 ). However, the exact mechanisms of PTBP1 function in these and other cancers have not been clearly understood, and more thorough studies may be needed. Overview 1 Structure 2 PTBP1 is an RNA-binding protein that belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs), the gene for which is located on chromosome 19p13.3 in humans. PTBP1 is 531 amino acids long, and has an N-terminal nuclear shuttling domain and four repeats of quasi-RRM domains that participate in the process of RNA-binding (Keppetipola et al., 2012 2012 ). PTBP1 has a preference for promoters, and coincides with RNA polymerase II (RNA Pol II). It exerts functions in RNA–protein complexes at the initiation of transcription of some genes (Swinburne et al., 2006 2006 ). PTBP1 and PTBP2 are both alternative splicing regulators to which many developmentally regulated exons show different sensitivities. The differential targeting arises from different cofactor interactions rather than different RNA interactions (Vuong et al., 2016 2016 ). In addition, many distinct phosphate modifications are located in the unstructured N-terminal regions of PTBP1 and PTBP2. PTBP1 is ubiquitously expressed, while the expression of PTBP2 is highly tissue-dependent (Licatalosi et al., 2012 2012 ; Yap et al., 2012 2012 ). PTBP1 and PTBP2 are non-conserved cryptic exon repressors, and they use CU microsatellites to repress both non-conserved cryptic exons and tissue-specific exons (Ling et al., 2016 2016 ). The location, structure, and formation of PTBP1 are shown in Fig. 1 1 . The PTBP1 gene is located on chromosome 19p13.3 in humans and has one N-terminal nuclear shuttling domain and four repeats of quasi-RNA recognition motif (RRM) domains. NLS: nuclear localization signal Regulation in normal cells 2 The expression of PTBP1 is controlled by other RNA-binding proteins at the transcriptional level. The presence of an alternative exon 11 results in two different splice isoforms of PTBP1 mRNA, and only the isoform that includes exon 11 is able to be transformed to the final product (Méreau et al., 2015 2015 ). PTBP1 plays a crucial role in the development of the skin of frogs in the Xenopus genus, and downregulation of PTBP1 results in developmental skin defects regulated by the RNA-binding protein Esrp1 (Méreau et al., 2015 2015 ; Noiret et al., 2017 2017 ). Esrp1 increases the expression of PTBP1 by promoting the inclusion of exon 11 in the Xenopus epidermis, and high levels of PTBP1 also cause nonsense-mediated decay by skipping exon 11 of PTBP’s own mRNA (Wollerton et al., 2004 2004 ; Méreau et al., 2015 2015 ). Another RNA-binding protein, MATR3, also regulates the function of PTBP1. During RNA processing, long mammalian introns prevent accurate exon identification, and LINE-derived sequences (LINEs) help with the selection by recruiting RNA-binding proteins, such as MATR3, to introns. Then, PTBP1 is recruited by MATR3 to bind to multivalent binding sites within LINEs. These two RNA-binding proteins repress splicing and 3' end processing within LINEs, which contributes to the function of LINEs (Attig et al., 2018 2018 ). At the post-transcriptional level, H 2 O 2 treatment decreases the protein level of PTBP1 by inducing a pre-existing protein degradation pathway in breast cells. H 2 O 2 promotes the expression of the oxidation-resistant C-α1 soluble guanylyl cyclase subunit to initiate the formation of PTBP1 dimers, resulting in subsequent protein degradation (Cote et al., 2012 2012 ). Functions of PTBP1 in normal cells 2 PTBP1 acts as a master regulator of splicing to activate or repress alternative exons depending on the pre-mRNA recruitment position. This regulation plays an important role mainly in the growth and differentiation of neuronal cells (Vuong et al., 2016 2016 ; Hamid and Makeyev, 2017 2017 ). PTBP1 blocks up-frameshift 1 (UPF1), a nonsense-mediated mRNA decay (NMD) protein, from binding to 3' untranslated regions (UTRs) to preserve the capacity of long 3' UTRs to regulate gene expression and the ability of NMD to accurately detect aberrant mRNAs (Ge et al., 2016 2016 ). PTBP1 also acts as a potential dynamic biomarker and is downregulated in the blood of individuals with Parkinson’s disease (PD) (Santiago and Potashkin, 2015b 2015b ). In addition to its primary role in the nervous system, PTBP1 plays critical roles in the activation of T cells in the immune system (la Porta et al., 2016 2016 ), the regulation of the cell cycle and apoptosis (Juan et al., 2014 2014 ), spermatogenesis and Xist induction (Juan et al., 2014 2014 ; Stork et al., 2018 2018 ), embryonic development (Dou and Zhang, 2016 2016 ), and erythrocyte development (Liu JH et al., 2018 2018 ). All the known or commonly recognized functions and regulatory mechanisms of PTBP1 in normal cells are shown in Fig. 2 2 . PTBP1 functions mainly in neuronal cells, in which it interacts with Pnky , miR-124, PSD-95, and Pbx1. PTBP1 regulates neurogenesis, NMD, transcription of neuronal genes, and tissue repair of neurogenic cells. It also regulates CD5 via alternative polyadenylation and CD40L and IL-2 via the PLCγ1/ERK1/2 and NF-κB pathways. PTBP1 regulates apoptosis via BIM and MCL1. miR-124: microRNA-124; PSD-95: postsynaptic density protein 95; NMD: nonsense-mediated mRNA decay; BIM: BCL-2-like 11; MCL1: myeloid cell leukemia 1; REST: repressor element 1 silencing transcription factor; PLCγ1: phospholipase Cγ1; ERK: extracellular signal-regulated kinase; NF-κB: nuclear factor-κB 2.3.1 Growth and differentiation of neuronal cells PTBP1 functions mainly in the process of neuronal cell growth, in which it reprograms developmental pre-mRNA splicing in neurons (Vuong et al., 2016 2016 ). PTBP1 suppresses the neuronal transcriptional program by controlling the activity of Pbx1 prior to the induction of neuronal progenitor cell development (Linares et al., 2015 2015 ). In the mammalian brain, alternative splicing is prevalent, and dynamic control of alternative splicing controls cell fate in the cerebral cortical development of mammals (Zhang XC et al., 2016 2016 ). PTBP1 also regulates alternative splicing with Pnky , a long non-coding RNA (lncRNA), in neural stem cells (NSCs) (Ramos et al., 2015 2015 ). Double-knockdown of Pnky and PTBP1 depletes the NSC population and enhances neurogenesis and neuronal differentiation (Ramos et al., 2015 2015 ), which suggests that the Pnky –PTBP1 complex leads to a splicing program, resulting in suppression during neurogenesis (Grammatikakis and Gorospe, 2016 2016 ). 2.3.2 T-cell activation and the immune system PTBP1 functions as a critical regulator of cluster of differentiation 4 (CD4) T-cell activation, which regulates the expression of CD40 ligand (CD40L) and interleukin-2 (IL-2) through the activation of the phospholipase Cγ1 (PLCγ1)/extracellular signal-regulated kinase 1/2 (ERK1/2) and nuclear factor-κB (NF-κB) pathways (la Porta et al., 2016 2016 ). It also regulates the expression of CD5 via alternative polyadenylation during human T-cell activation (Domingues et al., 2016 2016 ). PTBP1 also participates in CD46 alternative splicing regulation (Tang et al., 2016 2016 ). It is also upregulated in B lymphocytes and plays a critical role in B-cell selection in germinal centers (Monzón-Casanova et al., 2018 2018 ). Furthermore, Sasanuma et al. ( 2018 2018 ) have reported that PTBP1 is necessary for B cell receptor (BCR)-mediated antibody production. 2.3.3 Cell cycle and apoptosis BCL-2-like 11 (BIM), a pro-apoptotic protein, plays a crucial role in impaired or excessive apoptosis, which can contribute to degenerative disorders and tumorigenesis. Researchers have found that the downregulation of PTBP1 can inhibit BIM-mediated apoptosis (Juan et al., 2014 2014 ). Myeloid cell leukemia 1 (MCL1), a member of the BCL-2 protein family, is a crucial anti-apoptotic protein. A recent study demonstrated that PTBP1 represses MCL1 expression by destabilizing MCL1 mRNA and enhancing the miR-101-guided argonaute 2 (AGO2) interaction with MCL1 (Yang et al., 2018 2018 ). 2.3.4 Other functions of PTBP1 in cell biology PTBP1 is a splicing regulatory protein with multiple functions, and acts as a post-transcriptional regulation factor in many processes. It regulates cholesterol biosynthesis by regulating 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and low-density lipoprotein (LDL) receptor (LDLR), which are involved in the cholesterol biosynthesis process. These genes undergo alternative splicing, resulting in depletion of the enzyme for cholesterol biosynthesis (Medina et al., 2011 2011 ). The alternative splicing of dopamine receptor D 2 (DRD 2 ) is regulated by PTBP1. DRD 2 modulates the intracellular localization of PTBP1 by inhibiting cyclic adenosine monophosphate (cAMP)-dependent protein kinase A. PTBP1 enhances the inclusion of the alternative exon 6 to regulate the expression of the isoforms of DRD 2 , leading to the autoregulation of DRD 2 (Sasabe et al., 2011 2011 ). PTBP1 represses the splicing of exons of some genes (Llorian et al., 2016 2016 ). During the repression of the splicing of the c-src N1 exon, RRM 1 and RRM 2 of PTBP1 directly interact with the pyrimidine-rich internal loop of the U1 small nuclear RNA (snRNA) stem loop 4, which results in the prevention of further spliceosomal component assembly downstream and the U1 small nuclear ribonucleoprotein particle (snRNP) (Sharma et al., 2011 2011 ). PTBP1 plays a crucial role in the repression of defective splicing caused by ISCU intron mutation in patients who suffer from myopathy, and this repression of defective splicing leads to a drastic reduction in mutant transcripts (Nordin et al., 2012 2012 ). Roles in diseases other than cancer 2 PTBP1 plays important roles in various diseases. In most of these diseases, it functions mainly as a splicing factor that is regulated by several molecules, including maternally expressed gene 3 (MEG3), H19, miR-124, and glucose. The roles of PTBP1 in diseases other than cancer are shown in Table 1 1 . MEG3: maternally expressed gene 3; SHP: small heterodimer partner; RBM20: RNA binding motif protein 20; FHOD3: formin homology 2 domain containing 3; APP: amyloid precursor protein Disease Mechanism Function/effect Reference Cholestatic liver injury MEG3/PTBP1/SHP Disruption of bile acid (BA) homeostasis, elevation of liver enzymes, dysregulation of BA synthetic enzymes and metabolic genes Zhang et al., 2017 2017 Pulmonary arterial hypertension (1) ↓miR-124/PTBP1/PKM1 and PKM2 (2) H19/↓PTBP1/let-7 (1) Metabolic and proliferative abnormalities (2) Promote the progression of cholestatic liver fibrosis Kang et al., 2013 2013 ; Caruso et al., 2017 2017 ; Zhang et al., 2017 2017 ; Wang et al., 2019 2019 Fatty liver H19/↓PTBP1/sterol regulatory element-binding protein 1 Lipid accumulation; exacerbate the development of fatty liver Liu C et al., 2018 2018 ; del Rio-Moreno et al., 2019 2019 Hereditary myopathy with lactic acidosis PTBP1/ ISCU mis-splicing Substantial decrease in ISCU mis-splicing Rawcliffe et al., 2018 2018 Idiopathic dilated cardiomyopathy RBM20 and PTBP1/FHOD3 Functional cytoskeleton and sarcomere proteins Lorenzi et al., 2019 2019 Cardiovascular diseases (1) PTBP1/FHOD3 (2) PTBP1/exons 8/8a L-type CaV1.2 calcium channels (1) Alteration of CaV1.2 channel (2) Actin filament functional organization Tang et al., 2011 2011 ; Lorenzi et al., 2019 2019 Diabetes Glucose/insulin receptor/PTBP1/insulin Nuclear retention of PTBP1 and impaired insulin secretion Ehehalt et al., 2010 2010 ; Jeong et al., 2018 2018 Alzheimer’s disease miR-124/PTBP1/amyloid precursor protein Abnormal neuronal splicing of APP, β-amyloid peptide accumulation Smith et al., 2011 2011 ; Vaquero-Garcia et al., 2016 2016 Parkinson’s disease Unclear mRNA biomarker, longitudinally dynamic biomarker, aberrant alternative splicing Santiago and Potashkin, 2015a 2015a , 2015b 2015b Significance in cancers 1 Pathways in cancer 2 PTBP1 functions in many kinds of pathways, such as the epidermal growth factor receptor (EGFR) (Ferrarese et al., 2014 2014 ; Shi et al., 2018 2018 ), mitogen-activated protein kinase (MAPK) (Hollander et al., 2016 2016 ), phosphoinositide 3-kinase (PI3K)/Akt (Ouyang et al., 2018 2018 ), and hypoxia inducible factor-1α pathways (Shan et al., 2018 2018 ). It works mainly as a splicing factor and interacts with miR-124 and PKM splicing isoforms in various types of cancer. PTBP1 promotes the progression of glioblastomas and regulates apoptosis during colon tumorigenesis via these pathways. The pathways can be considered as potential targets for treating the corresponding diseases (Zhou et al., 2011 2011 ; Yao et al., 2015 2015 ; Wang et al., 2018 2018 ). PTBP1 mediates tissue-specific alternative splicing, which is important for the emergence of tissue identity during the process of tissue development. In glioblastomas, the loss of a brain-enriched microRNA (miR-124) leads to PTBP1 amplification. PTBP1 mediates annexin A7 (ANXA7) exon splicing, which eliminates the tumor suppressor functions and promotes glioblastoma progression (Ferrarese et al., 2014 2014 ). Furthermore, lineage-specific splicing of a brain-enriched cassette exon in ANXA7, a membrane-binding tumor suppressor, decreases endosomal targeting of the EGFR oncoprotein (Ferrarese et al., 2014 2014 ). To conclude, this mechanism enhances EGFR signaling to promote the progression of glioblastomas (Ferrarese et al., 2014 2014 ). Oncogenic KRAS mutations increase ELK1 transcription factor levels via the RAS-MAPK pathway, and this increase in ELK1 increases the transcription factors MYC and PTBP1. This process affects the proliferation, migration, and differentiation of colon cancer in a cell-context-specific and cell-type-specific manner. Moreover, PTBP1 promotes major triggers of colon tumorigenesis, including RAC1 , NUMB , and PKM splicing isoforms (Hollander et al., 2016 2016 ). PTBP1 also regulates apoptosis and the cell cycle to promote tumorigenesis (Zhang et al., 2018 2018 ). It also regulates the PTEN-PI3K/Akt pathway and the hypoxia inducible factor-1α pathway to alter tumor cell growth, migration, and invasion. The latter pathway is specifically involved in renal cell cancer (RCC) (Ouyang et al., 2018 2018 ; Shan et al., 2018 2018 ). However, the exact mechanisms of the participation of PTBP1 in the PI3K/Akt pathway and the hypoxia inducible factor-1α pathway have not been completely elucidated. Processes regulated by PTBP1 in cancer 2 3.2.1 Glycolysis PTBP1 acts as an alternative splicing repressor of the PKM1, leading to the expression of the PKM2 (Shinohara et al., 2016 2016 ). PTBP1 increases the transformation of PKM1 to PKM2, and the upregulation of PTBP1 is associated with the proliferation, invasion, and migration of human breast cancer, clear-cell renal cell carcinoma (ccRCC), and anaplastic large cell lymphoma (ALCL) (He et al., 2014 2014 ; Hwang et al., 2017 2017 ; Jiang et al., 2017 2017 ). The modulation of PKM alternative splicing and the upregulation of PTBP1 in pancreatic ductal adenocarcinoma (PDAC) cells confers drug resistance, which leads to the transition to drug-resistant PDAC (DR-PDAC) (Calabretta et al., 2016 2016 ). miR-145 inactivates the MAPK/ERK and PI3K/AKT pathways and impairs cancer-specific energy metabolism by inhibiting the c-Myc/PTBP1/PKMs axis in bladder cancer cells (Takai et al., 2017 2017 ). The expression of miR-145 downregulates c-Myc expression at the translation level, and c-Myc acts upstream of PTBP1 to positively regulate the expression of PTBP1 (Sachdeva et al., 2009 2009 ). Moreover, PKM2 is partly upregulated by PTBP1, and PKM2 increases the phosphorylation of Beclin-1 and mediates autophagic activation in acute myeloid leukemia with mutated nucleophosmin (Wang et al., 2019 2019 ). Serine and arginine-rich splicing factor 3 (SRSF3) is one of the splicing factors that regulate the alternative splicing of pre-mRNAs and enhance the inclusion of an alternative exon 4 to regulate its own expression (Guo et al., 2015 2015 ). The silencing of SRSF3 induces marked growth inhibition in human colon cancer cells and causes an increase in the PKM1/PKM2 ratio, which leads to a metabolic shift from glycolysis to oxidative phosphorylation. Subsequently, the cancer cells produce reactive oxygen species (ROS) and induce autophagic cell death (Taniguchi et al., 2018 2018 ). PTBP1 inhibits the inclusion of an exonic splicing suppressor in exon 4 by binding to it, which leads to the overexpression of full-length functional SRSF3 associated with oncogenesis. Specifically, in oral squamous cell carcinoma (OSCC) cells, SRSF3 exon 4 is damaged (Guo et al., 2015 2015 ). Apigenin (AP) and AIC-47 act as anticancer agents in the above diseases. AP ensures a high PKM1/PKM2 ratio in colon cancer cells by blocking the β-catenin/c-Myc/PTBP1 signaling pathway, which reduces PKM2 activity and expression to block cellular glycolysis and induces anti-colon cancer effects (Shan et al., 2017 2017 ). PTBP1 plays an important role in promoting the growth of chronic myeloid leukemia cells. In the treatment of chronic myeloid leukemia cells, AIC-47 and imatinib decrease the expression of PTBP1 and increase the PKM1 level, which strengthens the attack on cancer energy metabolism (Shinohara et al., 2016 2016 ). PKM2 alternative splicing may be a promising target for the treatment of ccRCC (Jiang et al., 2017 2017 ). PTBP1 is recruited to PKM pre-mRNA in DR-PDAC, and the knockdown of PTBP1 reduces its recruitment, which may improve the response of PDAC to chemotherapy if it is considered a new potential therapeutic target (Calabretta et al., 2016 2016 ). The upregulation of the expression of PKM1 promotes oxidative phosphorylation and reduces tumorigenesis (He et al., 2014 2014 ). 3.2.2 Apoptosis and proliferation In cancer cells, PTBP1 regulates apoptosis and proliferation through alternative splicing of MCL1 and adenosine deaminase acting on RNA 1 (ADAR1), respectively. MCL1 is an essential regulator of intrinsic apoptosis and is a member of the anti-apoptotic BCL2 family. PTBP1 regulates MCL1 mRNA by controlling the apoptotic response to tubulin chemotherapeutics, and the knockdown of PTBP1 increases MCL1 expression and MCL1 mRNA accumulation in the cytoplasm of cancer cells (Cui and Placzek, 2016 2016 ). PTBP1 mediates the translational mode of ADAR1 p110 by an internal ribosomal entry site (IRES)-like element. The protein levels of ADAR1 p110 are upregulated in glioma cells, which is critical for the maintenance of gliomagenesis. The knockdown of ADAR1 p110 significantly decreases the proliferation of glioma cells (Yang et al., 2015 2015 ). 3.2.3 Tumorigenesis Cell division control protein 42 homolog (CDC42) and the senescence-associated secretory phenotype (SASP) participate in tumorigenesis via PTBP1. CDC42 has two variants (CDC42-v1 and CDC42-v2) generated by alternative splicing, which act as the main regulators of filopodia formation regulated by PTBP1 in tumorigenesis. Knockdown of PTBP1 promotes the expression of CDC42-v2. CDC42-v2 functions as a tumor suppressor and is expressed in lower levels in ovarian tumor tissues, while CDC42-v1 has an opposite effect (He et al., 2015 2015 ). Thus PTBP1 plays a vital role in promoting ovarian cancer. PTBP1 controls SASP by regulating exocyst complex exo70 subunit (EXOC7), which is involved in intracellular trafficking. The inhibition of PTBP1 impairs immune surveillance, reducing the risk of tumorigenesis and preventing the protumorigenic effects of SASP. This inhibition functions as a safe and effective therapy against inflammation-driven cancer (Georgilis et al., 2018 2018 ). 3.2.4 Invasion, migration, and metastasis PTPB1 interacts with the mRNA of autophagy-related genes (ATGs) directly, and negatively regulates the ATG10 expression level, which plays an important role in colorectal cancer cells (Ouyang et al., 2018 2018 ). The downregulation of PTBP1 increases ATG10 levels, while the overexpression of PTBP1 decreases ATG10 expression. The knockdown of ATG10 induces the invasion and migration of colorectal cancer cells (Jo et al., 2017 2017 ). Thus, PTBP1 facilitates metastasis of colorectal cancer cells through downregulation of ATG10. Molecules regulating PTBP1 in cancer 2 3.3.1 LncRNAs The depletion of ovarian adenocarcinoma-amplified lncRNA (OVAAL), a commonly upregulated lncRNA that confers apoptotic resistance in cancer, triggers cellular senescence via p27 expression. PTBP1-mediated p27 expression is regulated by the competitive binding of p27 mRNA and OVAAL to PTBP1 (Sang et al., 2018 2018 ). Promotor of CDKN1A antisense DNA damage-activated RNA ( PANDAR ) is another lncRNA that is involved in the regulation of senescence and proliferation and is transcribed from the CDKN1A promoter. The upregulation of PANDAR results in a decreased level of the short pro-apoptotic BCL-X splice variant ( BCL-XS ), which is regulated by PTBP1. The overexpression of PTBP1 rescues this effect, which suggests that PANDAR regulates splicing events with its interaction partner PTBP1 (Pospiech et al., 2018 2018 ). All known or commonly recognized functions and regulatory roles of PTBP1 in cancer cells are shown in Fig. 3 3 . PTBP1 plays an important role in glycolysis, proliferation, invasion, apoptosis, and tumorigenesis. It is regulated by the miR-145/c-Myc and AP/β-catenin/c-Myc pathways. PTBP1 increases the transformation of PKM1 to PKM2, which is a crucial process for glycolysis. PKM2 increases the phosphorylation of Beclin-1 and mediates autophagic activation. PTBP1 inhibits the inclusion of an exonic splicing suppressor in exon 4 of the SRSF3 gene. This inhibition leads to the overexpression of SRSF3 and increases the transformation of PKM1 to PKM2. PTBP1 regulates tumorigenesis via CDC42-v1/v2 and regulates apoptosis via MCL1. CDC42: cell division control protein 42 homolog; MCL1: myeloid cell leukemia 1; SRSF3: serine and arginine-rich splicing factor 3; ERK: extracellular signal-regulated kinase; MEK: mitogen-activated protein kinase kinase; GSK-3: glycogen synthase kinase-3; PI3K: phosphoinositide 3-kinase; P: phosphorylation; AP: apigenin 3.3.2 MicroRNAs The Warburg effect is a well-known cancer-specific metabolic effect that shifts the metabolism from oxidative phosphorylation to glycolysis. miR-145 disturbs the Warburg effect by inhibiting the Kruppel-like factor 4 (KLF4)/PTBP1/PKMs pathway via specifically binding to the 3' UTR of KLF4 in human bladder cancer cells (Minami et al., 2017 2017 ). miR-133b functions as a tumor suppressor by negatively regulating the Warburg effect in gastric cancer cells. This regulation reduces PTBP1 expression at the translational level. For the treatment of gastric cancer, knockdown of PTBP1 and ectopic expression of miR-133b switch the PKM isoform expression from PKM2 to PKM1 to inhibit cell proliferation (Sugiyama et al., 2016 2016 ). The overexpression of linc-ROR (long intergenic non-protein coding RNA, regulator of reprogramming) increases basal autophagy in pancreatic cancer cells via the miR-124/PTBP1/PKM2 axis. miR-124 overexpression negatively correlates with linc-ROR expression and reduces PTBP1 and PKM2 levels to enhance gemcitabine-induced cell apoptosis (Li et al., 2016 2016 ). miR-124 also regulates a DDX6/c-Myc/PTBP1 positive feedback circuit, which indicates its important role in the maintenance of the Warburg effect in colorectal cancer (Taniguchi et al., 2015 2015 ). 3.3.3 Other molecules that regulate PTBP1 in cancer In addition to lncRNAs and microRNAs, other molecules regulate PTBP1, including NOVA1, MYCN, BAF45d, H 2 O 2 , and ELK1. PTBP1 coordinates with NOVA1 to promote the splicing of human telomerase reverse transcriptase ( hTERT ) transcripts and to produce full-length TERT , which promotes telomere maintenance in cancer cells. The knockdown of PTBP1 results in an increased expression of PTBP2, and PTBP2 interacts with NOVA1 to prevent the interaction of NOVA1 with hTERT pre-mRNA (Sayed et al., 2018 2018 ). MYCN directly binds to the promoter regions of PTBP1 to regulate the expression of this key splicing factor in neuroblastoma (NBL). Knocking down PTBP1 leads to repressed growth of NBL cells, and PTBP1 displays a unique expression pattern in MYCN-amplified tumors and may act as a potential therapeutic target in high-risk NBL with MYCN amplification (Zhang SL et al., 2016 2016 ). BAF45d, part of the switch non-fermentable complex in glioblastoma, regulates PTBP1. Its function suggests a reciprocal interplay between transcription and RNA splicing regulation (Aldave et al., 2018 2018 ). H 2 O 2 decreases PTBP1 and hnRNP A2/B1 splice factors at the protein level, which functions as a treatment for breast cancer (Cote et al., 2012 2012 ). The transcription factor ETS domain-containing protein ELK1 induces the transcription factor MYC and then induces the alternative splicing factor PTBP1 in colon cancer (Hollander et al., 2016 2016 ). Roles in various cancers 2 PTBP1 participates in various cancers mainly as a splicing factor, thereby playing a critical role in the processes of migration, metastasis, proliferation, and carcinogenesis. It is regulated by various molecules, such as miR-137, miR-206, and miR-133b. The roles of PTBP1 in various cancers are shown in Table 2 2 . PAX3: paired box 3; FOXO1: forkhead box protein O1; HPV: human papillomavirus; FGFR: fibroblast growth factor receptor; HIF-1α: hypoxia-inducible factor-1α; USP5: ubiquitin specific peptidase 5; CircSMARCA5: circular RNA SMARCA5; sGC: soluble guanylyl cyclase; EMT: epithelial-mesenchymal transition; MAPK: mitogen-activated protein kinase; TRAIL: TNF-related apoptosis-inducing ligand Type of cancer Mechanism Function/effect Reference Melanoma PTBP1/CD44v6 Migration of melanoma brain metastasis Marzese et al., 2015 2015 Hepatoma miR137 and miR206/↓PTBP1/PKM1 Negative effects related to tissue characteristics and carcinogenesis Taniguchi et al., 2018 2018 Rhabdomyosarcoma ↓miR-133b/PAX3-FOXO1/PTBP1 and ↓miR-1 and ↓miR-133b/PTBP1 Positive regulation of cancer-specific energy metabolism Sugito et al., 2017 2017 Cervical cancer HPV infection/PTBP1 Promotion of DNA replication and cancer cell proliferation Xu et al., 2019 2019 Acute myeloid leukemia with mutated nucleophosmin PTBP1/PKM2/phosphorylation of Beclin-1 Autophagic activation and cancer cell survival Wang et al., 2019 2019 Anaplastic large cell lymphoma PTBP1/PKM2/STAT3 Transcription of genes involved in cell survival and proliferation, oncogenesis Hwang et al., 2017 2017 Chronic myeloid leukemia AIC-47 and imatinib/↓PBTP1/↓PKM2 Perturbation of energy metabolism Shinohara et al., 2016 2016 Gastric cancer miR-133b/↓PTBP1 Negative regulation of the Warburg effect Sugiyama et al., 2016 2016 Oral squamous cell carcinoma PTBP1/SRSF3 Overexpression of SRSF3 , oncogenesis Guo et al., 2015 2015 Ovarian cancer (1) PTBP1/CDC42 (2) ↓OVAAL/PTBP1/p27 (1) Filopodia formation, proliferation, invasiveness (2) Cellular senescence He et al., 2015 2015 ; Sang et al., 2018 2018 Bladder cancer (1) miR-145/↓KLF4/↓PTBP1/↓PKMs (2) PTBP1/ MEIS2 /PKM2 (1) Perturbation of the Warburg effect and inhibition of carcinogenesis (2) Lymph node metastasis, tumor stage, histological grade, and poor prognosis Minami et al., 2017 2017 ; Takai et al., 2017 2017 ; Xie et al., 2019 2019 Pancreatic ductal adenocarcinoma (1) Gemcitabine/PTBP1/PKM2 (2) Linc-ROR/↓miR-124/PTBP1/PKM2 (1) Resistance to gemcitabine (2) Resistance to gemcitabine Calabretta et al., 2016 2016 ; Li et al., 2016 2016 Breast cancer (1) PTBP1/PKM2 (2) PTBP1/PTEN-PI3K/Akt (3) PTBP1/FGFR1α/FGFR1β splicing (1) Warburg effect, tumorigenesis, and transformation properties (2) Proliferation, invasion, and metastasis (3) Proliferation and migration He et al., 2014 2014 ; Ouyang et al., 2018 2018 ; Zhao et al., 2019 2019 Renal cell cancer (1) PTBP1/PKM2 (2) ↓PTBP1/HIF-1α pathway (1) Proliferation, migration, and invasion (2) Inhibit cell migration, invasion, and angiogenesis Jiang et al., 2017 2017 ; Shan et al., 2018 2018 Glioblastoma (1) ↓miR-124/PTBP1/ANXA7/EGFR (2) BAF45d/PTBP1 (3) PTBP1/USP5 (4) ↓CircSMARCA5/SRSF1/SRSF3/PTBP1 (1) Glioblastoma progression (2) Malignant phenotype and undifferentiated cellular state (3) Oncogenesis (4) Invasion and migration Izaguirre et al., 2012 2012 ; Ferrarese et al., 2014 2014 ; Aldave et al., 2018 2018 ; Barbagallo et al., 2018 2018 Neuroblastoma (1) MYCN/PTBP1/PKM2 (2) Hydrogen peroxide/PTBP1/sGC (1) Proliferation, metastasis, and poor overall survival (2) Cellular adaptation to oxidative stress Cote et al., 2012 2012 ; Zhang SL et al., 2016 2016 Glioma (1) PTBP1/RTN4 (2) PTBP1/IRES-like element/ADAR1 p110 (1) Proliferation, invasion, and migration (2) Gliomagenesis and proliferation Cheung et al., 2009 2009 ; Yang et al., 2015 2015 Colorectal cancer (1) ↓miR-1 and ↓miR-133b/PTBP1/PKM2 (2) DDX6/c-Myc/PTBP1 (3) PTBP1/ATG10/EMT-associated proteins (4) PTBP1/cortactin (1) Warburg effect (2) Warburg effect (3) EMT, migration and invasion (4) Migration and invasion Taniguchi et al., 2015 2015 , 2016 2016 ; Jo et al., 2017 2017 ; Wang et al., 2017 2017 Colon cancer (1) ELK1/MYC/PTBP1/RAS-MAPK (2) ↓TPBP1/TRAIL and ↓PTBP1/PKM2→PKM1 (3) Apigenin/↓PTBP1/↓PKM2 (1) Tumorigenesis (2) Apoptosis and perturbation of the Warburg effect (3) Warburg effect and oncogenesis Hollander et al., 2016 2016 ; Kumazaki et al., 2016 2016 ; Shan et al., 2017 2017 Conclusions and perspective 1 Recently, the most innovative therapy for cancer has been immunotherapy. There are two basic forms of immunotherapy: immune checkpoint therapy and chimeric antigen receptor (CAR) T-cell therapy (Iwai et al., 2017 2017 ; Miyajima et al., 2017 2017 ; Finney et al., 2019 2019 ; Ren et al., 2019 2019 ). Two of the most important pathways in immune checkpoint therapy are the programmed death 1 (PD-1) and the cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) pathways. The reason why cancer cells escape from the immune system is that cancer cells inhibit the immune system of our body in different ways, and these two pathways reactivate the immune system to kill all cancer cells (Iwai et al., 2017 2017 ; Miyajima et al., 2017 2017 ). CAR T-cell therapy targets mainly CD19 and is used to treat B-cell lymphoma (Brown and Mackall, 2019 2019 ). Compared with these two main therapies to treat cancer, PTBP1 has the potential to act as another core molecule in immunotherapy. As a splicing factor, PTBP1 regulates many different ligands and receptors of the immune system, including CD40L, CD5, CD46, and IL-2 (Domingues et al., 2016 2016 ; la Porta et al., 2016 2016 ; Tang et al., 2016 2016 ). PTBP1 is also upregulated in B lymphocytes and plays an important role in B-cell selection (Monzón-Casanova et al., 2018 2018 ). All of these functions can be considered as supporting the immune system, and reveal the potential of PTBP1 in the clinical treatment of cancer. PKM2 functions as an essential gene for the Warburg effect, a cancer-specific energy metabolism state that is regulated by the alternative splicing of PTBP1 (Hwang et al., 2017 2017 ; Taniguchi et al., 2018 2018 ). PTBP1 is a splicer of PKM mRNA and a positive regulator of the Warburg effect. These roles suggest that PTBP1 may be a useful therapeutic target for the Warburg effect (Sugito et al., 2017 2017 ; Wang et al., 2019 2019 ). Furthermore, miR-133b can reduce PTBP1 expression and silence the Warburg effect as a tumor suppressor in gastric cancer (Sugiyama et al., 2016 2016 ). PTBP1 functions in almost all cell types in humans. It mediates growth, differentiation, and proliferation and is regulated by various molecules, including miRNA, lncRNA, RNA-binding protein, H 2 O 2 , and other splicing factors. PTBP1 participates in various diseases, including neurodegenerative diseases, cardiovascular diseases, and some cancers, including colon cancer, colorectal cancer, RCC, breast cancer, glioma, NBL, and glioblastoma. In cancers, PTBP1 participates mainly in glycolysis, apoptosis, proliferation, tumorigenesis, invasion, and migration. These findings identify PTBP1 as a novel potential candidate for clinical diagnosis and targeted therapy. It is interesting that lncRNA PNCTR limits the alternative splicing of PTBP1 and inhibits the apoptosis of cancer cells (Bubenik and Swanson, 2018 2018 ). In normal cells, PTBP1 promotes apoptosis through the regulation of BIM and MCL1 (Juan et al., 2014 2014 ; Yang et al., 2018 2018 ). Moreover, PTBP1 depletion protects cancer cells from antitubulin agent-induced apoptosis via an MCL1-dependent mechanism (Cui and Placzek, 2016 2016 ). PTBP1 may be a useful therapeutic target for the Warburg effect and tumor cell metabolism reprogramming, but its exact functions in cellular apoptosis and tumor cells are still unclear. The relevant mechanisms are worth exploring in further studies. References G Aldave , M Gonzalez-Huarriz , A Rubio , 等 . The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma . Neuro-Oncology , 2018 . 20 ( 7 ): 930 - 941 . 29373718 DOI: 10.1093/neuonc/noy007 http://doi.org/10.1093/neuonc/noy007 . The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma J Attig , F Agostini , C Gooding , 等 . Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing . Cell , 2018 . 174 ( 5 ): 1067 - 1081e17 . 30078707 DOI: 10.1016/j.cell.2018.07.001 http://doi.org/10.1016/j.cell.2018.07.001 . Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing D Barbagallo , A Caponnetto , M Cirnigliaro , 等 . CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB . Int J Mol Sci , 2018 . 19 ( 2 ): 480 DOI: 10.3390/ijms19020480 http://doi.org/10.3390/ijms19020480 . CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB DL Black . Mechanisms of alternative pre-messenger RNA splicing . Annu Rev Biochem , 2003 . 72 291 - 336 . 12626338 DOI: 10.1146/annurev.biochem.72.121801.161720 http://doi.org/10.1146/annurev.biochem.72.121801.161720 . Mechanisms of alternative pre-messenger RNA splicing CE Brown , CL Mackall . CAR T cell therapy: inroads to response and resistance . Nat Rev Immunol , 2019 . 19 ( 2 ): 73 - 74 . 30631206 DOI: 10.1038/s41577-018-0119-y http://doi.org/10.1038/s41577-018-0119-y . CAR T cell therapy: inroads to response and resistance J Bubenik , MS Swanson . Strring up cancer with lncRNA . Mol Cell , 2018 . 72 ( 3 ): 399 - 401 . 30388407 DOI: 10.1016/j.molcel.2018.10.026 http://doi.org/10.1016/j.molcel.2018.10.026 . Strring up cancer with lncRNA A Busch , KJ Hertel . Evolution of SR protein and hnRNP splicing regulatory factors . Wiley Interdiscip Rev RNA , 2012 . 3 ( 1 ): 1 - 12 . 21898828 DOI: 10.1002/wrna.100 http://doi.org/10.1002/wrna.100 . Evolution of SR protein and hnRNP splicing regulatory factors S Calabretta , P Bielli , I Passacantilli , 等 . Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells . Oncogene , 2016 . 35 ( 16 ): 2031 - 2039 . 26234680 DOI: 10.1038/onc.2015.270 http://doi.org/10.1038/onc.2015.270 . Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells P Caruso , BJ Dunmore , K Schlosser , 等 . Identification of microRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2 . Circulation , 2017 . 136 ( 25 ): 2451 - 2467 . 28971999 DOI: 10.1161/circulationaha.117.028034 http://doi.org/10.1161/circulationaha.117.028034 . Identification of microRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2 HC Cheung , T Hai , W Zhu , 等 . Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines . Brain , 2009 . 132 ( 8 ): 2277 - 2288 . 19506066 DOI: 10.1093/brain/awp153 http://doi.org/10.1093/brain/awp153 . Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines A Corrionero , J Valcarcel . RNA processing: redrawing the map of charted territory . Mol Cell , 2009 . 36 ( 6 ): 918 - 919 . 20064456 DOI: 10.1016/j.molcel.2009.12.004 http://doi.org/10.1016/j.molcel.2009.12.004 . RNA processing: redrawing the map of charted territory GJ Cote , W Zhu , A Thomas , 等 . Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells . PLoS ONE , 2012 . 7 ( 7 ): e41099 22911749 DOI: 10.1371/journal.pone.0041099 http://doi.org/10.1371/journal.pone.0041099 . Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells J Cui , WJ Placzek . PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics . Cell Death Differ , 2016 . 23 ( 10 ): 1681 - 1690 . 27367564 DOI: 10.1038/cdd.2016.60 http://doi.org/10.1038/cdd.2016.60 . PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics M del Rio-Moreno , E Alors-Perez , S Gonzalez-Rubio , 等 . Dysregulation of the splicing machinery is associated to the development of non-alcoholic fatty liver disease . J Clin Endocrinol Metab , 2019 . 104 ( 8 ): 3389 - 3402 . 30901032 DOI: 10.1210/jc.2019-00021 http://doi.org/10.1210/jc.2019-00021 . Dysregulation of the splicing machinery is associated to the development of non-alcoholic fatty liver disease RG Domingues , I Lago-Baldaia , I Pereira-Castro , 等 . CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204 . Eur J Immunol , 2016 . 46 ( 6 ): 1490 - 1503 . 27005442 DOI: 10.1002/eji.201545663 http://doi.org/10.1002/eji.201545663 . CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204 XM Dou , XS Zhang . RNA-binding protein PTB in spermatogenesis: progress in studies . Nat J Androl , 2016 . 22 ( 9 ): 856 - 860 . (in Chinese) . RNA-binding protein PTB in spermatogenesis: progress in studies F Ehehalt , K Knoch , K Erdmann , 等 . Impaired insulin turnover in islets from type 2 diabetic patients . Islets , 2010 . 2 ( 1 ): 30 - 36 . 21099291 DOI: 10.4161/isl.2.1.10098 http://doi.org/10.4161/isl.2.1.10098 . Impaired insulin turnover in islets from type 2 diabetic patients R Ferrarese , GR Harsh IV , AK Yadav , 等 . Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression . J Clin Invest , 2014 . 124 ( 7 ): 2861 - 2876 . 24865424 DOI: 10.1172/jci68836 http://doi.org/10.1172/jci68836 . Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression OC Finney , H Brakke , S Rawlings-Rhea , 等 . CD19 CAR T cell product and disease attributes predict leukemia remission durability . J Clin Invest , 2019 . 129 ( 5 ): 2123 - 2132 . 30860496 DOI: 10.1172/jci125423 http://doi.org/10.1172/jci125423 . CD19 CAR T cell product and disease attributes predict leukemia remission durability XD Fu , Jr M Ares . Context-dependent control of alternative splicing by RNA-binding proteins . Nat Rev Genet , 2014 . 15 ( 10 ): 689 - 701 . 25112293 DOI: 10.1038/nrg3778 http://doi.org/10.1038/nrg3778 . Context-dependent control of alternative splicing by RNA-binding proteins ZY Ge , BL Quek , KL Beemon , 等 . Polypyrimidine tract binding protein 1 protects mRNAs from recognition by the nonsense-mediated mRNA decay pathway . eLife, 5:e11155 , 2016 . DOI: 10.7554/eLife.11155 http://doi.org/10.7554/eLife.11155 . Polypyrimidine tract binding protein 1 protects mRNAs from recognition by the nonsense-mediated mRNA decay pathway A Georgilis , S Klotz , CJ Hanley , 等 . PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells . Cancer Cell , 2018 . 34 ( 1 ): 85 - 102e9 . 29990503 DOI: 10.1016/j.ccell.2018.06.007 http://doi.org/10.1016/j.ccell.2018.06.007 . PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells A Ghetti , S Pinol-Roma , WM Michael , 等 . hnRNP 1, the polyprimidine tract-binding protein: distinct nuclear localization and association with hnRNAs . Nucleic Acids Res , 1992 . 20 ( 14 ): 3671 - 3678 . 1641332 DOI: 10.1093/nar/20.14.3671 http://doi.org/10.1093/nar/20.14.3671 . hnRNP 1, the polyprimidine tract-binding protein: distinct nuclear localization and association with hnRNAs I Grammatikakis , M Gorospe . Identification of neural stem cell differentiation repressor complex Pnky -PTBP1 . Stem Cell Investig, 3:10 , 2016 . Identification of neural stem cell differentiation repressor complex Pnky-PTBP1 JH Guo , J Jia , R Jia . PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells . Sci Rep , 2015 . 5 ( 1 ): 14548 26416554 DOI: 10.1038/srep14548 http://doi.org/10.1038/srep14548 . PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells FM Hamid , EV Makeyev . A mechanism underlying position-specific regulation of alternative splicing . Nucleic Acids Res , 2017 . 45 ( 21 ): 12455 - 12468 . 30053257 DOI: 10.1093/nar/gkx901 http://doi.org/10.1093/nar/gkx901 . A mechanism underlying position-specific regulation of alternative splicing W Han , L Wang , B Yin , 等 . Characterization of a novel posttranslational modification in polypyrimidine tract-binding proteins by SUMO1 . BMB Rep , 2014 . 47 ( 4 ): 233 - 238 . 24286314 DOI: 10.5483/bmbrep.2014.47.4.140 http://doi.org/10.5483/bmbrep.2014.47.4.140 . Characterization of a novel posttranslational modification in polypyrimidine tract-binding proteins by SUMO1 X He , AD Arslan , TT Ho , 等 . Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties . Oncogenesis , 2014 . 3 ( 1 ): e84 24418892 DOI: 10.1038/oncsis.2013.47 http://doi.org/10.1038/oncsis.2013.47 . Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties XL He , CF Yuan , JL Yang . Regulation and functional significance of CDC42 alternative splicing in ovarian cancer . Oncotarget , 2015 . 6 ( 30 ): 29651 - 29663 . 26336992 . Regulation and functional significance of CDC42 alternative splicing in ovarian cancer D Hollander , M Donyo , N Atias , 等 . A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1 . Genome Res , 2016 . 26 ( 4 ): 541 - 553 . 26860615 DOI: 10.1101/gr.193169.115 http://doi.org/10.1101/gr.193169.115 . A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1 SR Hwang , C Murga-Zamalloa , N Brown , 等 . Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma . Lab Invest , 2017 . 97 ( 8 ): 962 - 970 . 28414323 DOI: 10.1038/labinvest.2017.39 http://doi.org/10.1038/labinvest.2017.39 . Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma Y Iwai , J Hamanishi , K Chamoto , 等 . Cancer immunotherapies targeting the PD-1 signaling pathway . J Biomed Sci , 2017 . 24 ( 1 ): 26 28376884 DOI: 10.1186/s12929-017-0329-9 http://doi.org/10.1186/s12929-017-0329-9 . Cancer immunotherapies targeting the PD-1 signaling pathway DI Izaguirre , W Zhu , T Hai , 等 . PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis . Mol Carcinog , 2012 . 51 ( 11 ): 895 - 906 . 21976412 DOI: 10.1002/mc.20859 http://doi.org/10.1002/mc.20859 . PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis DE Jeong , S Heo , JH Han , 等 . Glucose controls the expression of polypyrimidine tract-binding protein 1 via the insulin receptor signaling pathway in pancreatic β cells . Mol Cells , 2018 . 41 ( 10 ): 909 - 916 . 30165730 . Glucose controls the expression of polypyrimidine tract-binding protein 1 via the insulin receptor signaling pathway in pancreatic β cells JY Jiang , X Chen , H Liu , 等 . Polypyrimidine tract-binding protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM . Am J Cancer Res , 2017 . 7 ( 2 ): 245 - 259 . 28337374 . Polypyrimidine tract-binding protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM YK Jo , SA Roh , H Lee , 等 . Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells . Cancer Lett , 2017 . 385 21 - 27 . 27836735 DOI: 10.1016/j.canlet.2016.11.002 http://doi.org/10.1016/j.canlet.2016.11.002 . Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells WC Juan , X Roca , ST Ong . Identification of cis -acting elements and splicing factors involved in the regulation of BIM pre-mRNA splicing . PLoS ONE , 2014 . 9 ( 4 ): e95210 24743263 DOI: 10.1371/journal.pone.0095210 http://doi.org/10.1371/journal.pone.0095210 . Identification of cis-acting elements and splicing factors involved in the regulation of BIM pre-mRNA splicing K Kang , X Peng , X Zhang , 等 . MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells . J Biol Chem , 2013 . 288 ( 35 ): 25414 - 25427 . 23853098 DOI: 10.1074/jbc.M113.460287 http://doi.org/10.1074/jbc.M113.460287 . MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells N Keppetipola , S Sharma , Q Li , 等 . Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2 . Crit Rev Biochem Mol Biol , 2012 . 47 ( 4 ): 360 - 378 . 22655688 DOI: 10.3109/10409238.2012.691456 http://doi.org/10.3109/10409238.2012.691456 . Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2 M Kumazaki , H Shinohara , K Taniguchi , 等 . Perturbation of the Warburg effect increases the sensitivity of cancer cells to trail-induced cell death . Exp Cell Res , 2016 . 347 ( 1 ): 133 - 142 . 27453209 DOI: 10.1016/j.yexcr.2016.07.022 http://doi.org/10.1016/j.yexcr.2016.07.022 . Perturbation of the Warburg effect increases the sensitivity of cancer cells to trail-induced cell death J la Porta , R Matus-Nicodemos , A Valentin-Acevedo , 等 . The RNA-binding protein, polypyrimidine tract-binding protein 1 (PTBP1) is a key regulator of CD4 T cell activation . PLoS ONE , 2016 . 11 ( 8 ): e0158708 27513449 DOI: 10.1371/journal.pone.0158708 http://doi.org/10.1371/journal.pone.0158708 . The RNA-binding protein, polypyrimidine tract-binding protein 1 (PTBP1) is a key regulator of CD4 T cell activation CG Li , ZM Zhao , ZP Zhou , 等 . Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis . Cancer Chemother Pharmacol , 2016 . 78 ( 6 ): 1199 - 1207 . 27785603 DOI: 10.1007/s00280-016-3178-4 http://doi.org/10.1007/s00280-016-3178-4 . Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis DD Licatalosi , M Yano , JJ Fak , 等 . Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain . Genes Dev , 2012 . 26 ( 14 ): 1626 - 1642 . 22802532 DOI: 10.1101/gad.191338.112 http://doi.org/10.1101/gad.191338.112 . Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain AJ Linares , CH Lin , A Damianov , 等 . The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation . eLife, 4: e09268 , 2015 . DOI: 10.7554/eLife.09268 http://doi.org/10.7554/eLife.09268 . The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation JP Ling , R Chhabra , JD Merran , 等 . PTBP1 and PTBP2 repress nonconserved cryptic exons . Cell Rep , 2016 . 17 ( 1 ): 104 - 113 . 27681424 DOI: 10.1016/j.celrep.2016.08.071 http://doi.org/10.1016/j.celrep.2016.08.071 . PTBP1 and PTBP2 repress nonconserved cryptic exons C Liu , Z Yang , J Wu , 等 . Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis . Hepatology , 2018 . 67 ( 5 ): 1768 - 1783 . 29140550 DOI: 10.1002/hep.29654 http://doi.org/10.1002/hep.29654 . Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis JH Liu , YP Li , JY Tong , 等 . Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development . Nat Commun , 2018 . 9 ( 1 ): 4386 30349036 DOI: 10.1038/s41467-018-06883-x http://doi.org/10.1038/s41467-018-06883-x . Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development M Llorian , S Schwartz , TA Clark , 等 . Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB . Nat Struct Mol Biol , 2010 . 17 ( 9 ): 1114 - 1123 . 20711188 DOI: 10.1038/nsmb.1881 http://doi.org/10.1038/nsmb.1881 . Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB M Llorian , C Gooding , N Bellora , 等 . The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators . Nucleic Acids Res , 2016 . 44 ( 18 ): 8933 - 8950 . 27317697 DOI: 10.1093/nar/gkw560 http://doi.org/10.1093/nar/gkw560 . The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators P Lorenzi , A Sangalli , S Fochi , 等 . RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3 . Int J Biochem Cell Biol , 2019 . 106 74 - 83 . 30468920 DOI: 10.1016/j.biocel.2018.11.009 http://doi.org/10.1016/j.biocel.2018.11.009 . RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3 DM Marzese , M Liu , JL Huynh , 等 . Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome . Pigment Cell Melanoma Res , 2015 . 28 ( 1 ): 82 - 93 . 25169209 DOI: 10.1111/pcmr.12307 http://doi.org/10.1111/pcmr.12307 . Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome MW Medina , F Gao , D Naidoo , 等 . Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake . PLoS ONE , 2011 . 6 ( 4 ): e19420 21559365 DOI: 10.1371/journal.pone.0019420 http://doi.org/10.1371/journal.pone.0019420 . Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake A Méreau , V Anquetil , H Lerivray , 等 . A posttranscriptional mechanism that controls Ptbp1 abundance in the Xenopus epidermis . Mol Cell Biol , 2015 . 35 ( 4 ): 758 - 768 . 25512611 DOI: 10.1128/mcb.01040-14 http://doi.org/10.1128/mcb.01040-14 . A posttranscriptional mechanism that controls Ptbp1 abundance in the Xenopus epidermis K Minami , K Taniguchi , N Sugito , 等 . MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells . Oncotarget , 2017 . 8 ( 20 ): 33064 - 33077 . 28380435 . MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells M Miyajima , BH Zhang , Y Sugiura , 等 . Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior . Nat Immunol , 2017 . 18 ( 12 ): 1342 - 1352 . 29058703 DOI: 10.1038/ni.3867 http://doi.org/10.1038/ni.3867 . Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior E Monzón-Casanova , M Screen , MD Díaz-Muñoz , 等 . The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers . Nat Immunol , 2018 . 19 ( 3 ): 267 - 278 . 29358707 DOI: 10.1038/s41590-017-0035-5 http://doi.org/10.1038/s41590-017-0035-5 . The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers M Noiret , A Méreau , G Angrand , 等 . Robust identification of Ptbp1-dependent splicing events by a junction-centric approach in Xenopus laevis . Dev Biol , 2017 . 426 ( 2 ): 449 - 459 . 27546377 DOI: 10.1016/j.ydbio.2016.08.021 http://doi.org/10.1016/j.ydbio.2016.08.021 . Robust identification of Ptbp1-dependent splicing events by a junction-centric approach in Xenopus laevis A Nordin , E Larsson , M Holmberg . The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1 . Hum Mutat , 2012 . 33 ( 3 ): 467 - 470 . 22125086 DOI: 10.1002/humu.22002 http://doi.org/10.1002/humu.22002 . The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1 FC Oberstrass , SD Auweter , M Erat , 等 . Structure of PTB bound to RNA: specific binding and implications for splicing regulation . Science , 2005 . 309 ( 5743 ): 2054 - 2057 . 16179478 DOI: 10.1126/science.1114066 http://doi.org/10.1126/science.1114066 . Structure of PTB bound to RNA: specific binding and implications for splicing regulation GQ Ouyang , L Xiong , ZP Liu , 等 . Inhibition of autophagy potentiates the apoptosis-inducing effects of photodynamic therapy on human colon cancer cells . Photodiagn Photodyn Ther , 2018 . 21 396 - 403 . DOI: 10.1016/j.pdpdt.2018.01.010 http://doi.org/10.1016/j.pdpdt.2018.01.010 . Inhibition of autophagy potentiates the apoptosis-inducing effects of photodynamic therapy on human colon cancer cells N Pospiech , H Cibis , L Dietrich , 等 . Identification of novel PANDAR protein interaction partners involved in splicing regulation . Sci Rep , 2018 . 8 ( 1 ): 2798 29434205 DOI: 10.1038/s41598-018-21105-6 http://doi.org/10.1038/s41598-018-21105-6 . Identification of novel PANDAR protein interaction partners involved in splicing regulation AD Ramos , RE Andersen , SJ Liu , 等 . The long noncoding RNA Pnky regulates neuronal differentiation of embryonic and postnatal neural stem cells . Cell Stem Cell , 2015 . 16 ( 4 ): 439 - 447 . 25800779 DOI: 10.1016/j.stem.2015.02.007 http://doi.org/10.1016/j.stem.2015.02.007 . The long noncoding RNA Pnky regulates neuronal differentiation of embryonic and postnatal neural stem cells DFR Rawcliffe , L Osterman , A Nordin , 等 . PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis . Mol Genet Genomic Med , 2018 . 6 ( 6 ): 887 - 897 . 30209894 DOI: 10.1002/mgg3.413 http://doi.org/10.1002/mgg3.413 . PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis SS Ren , JW Deng , M Hong , 等 . Ethical considerations of cellular immunotherapy for cancer . J Zhejiang Univ-Sci B (Biomed & Biotechnol) , 2019 . 20 ( 1 ): 23 - 31 . DOI: 10.1631/jzus.B1800421 http://doi.org/10.1631/jzus.B1800421 . Ethical considerations of cellular immunotherapy for cancer M Sachdeva , SM Zhu , FT Wu , 等 . p53 represses c-Myc through induction of the tumor suppressor miR-145 . Proc Natl Acad Sci USA , 2009 . 106 ( 9 ): 3207 - 3212 . DOI: 10.1073/pnas.0808042106 http://doi.org/10.1073/pnas.0808042106 . p53 represses c-Myc through induction of the tumor suppressor miR-145 B Sang , YY Zhang , ST Guo , 等 . Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence . Proc Natl Acad Sci USA , 2018 . 115 ( 50 ): E11661 - E11670 . DOI: 10.1073/pnas.1805950115 http://doi.org/10.1073/pnas.1805950115 . Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence JA Santiago , JA Potashkin . Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson’s disease patients . PLoS ONE , 2015 . 10 ( 11 ): e0142582 26566043 DOI: 10.1371/journal.pone.0142582 http://doi.org/10.1371/journal.pone.0142582 . Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson’s disease patients JA Santiago , JA Potashkin . Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease . Proc Natl Acad Sci USA , 2015 . 112 ( 7 ): 2257 - 2262 . DOI: 10.1073/pnas.1423573112 http://doi.org/10.1073/pnas.1423573112 . Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease T Sasabe , E Futai , S Ishiura . Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D 2 . J Neurochem , 2011 . 116 ( 1 ): 76 - 81 . 21054383 DOI: 10.1111/j.1471-4159.2010.07086.x http://doi.org/10.1111/j.1471-4159.2010.07086.x . Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D2 H Sasanuma , M Ozawa , N Yoshida . RNA-binding protein Ptbp1 is essential for BCR-mediated antibody production . Int Immunol , 2018 . 31 ( 3 ): 157 - 166 . DOI: 10.1093/intimm/dxy077 http://doi.org/10.1093/intimm/dxy077 . RNA-binding protein Ptbp1 is essential for BCR-mediated antibody production ME Sayed , L Yuan , JD Robin , 等 . NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells . Oncogene , 2018 . 38 ( 16 ): 2937 - 2952 . 30568224 DOI: 10.1038/s41388-018-0639-8 http://doi.org/10.1038/s41388-018-0639-8 . NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells H Shan , P Hou , M Zhang , 等 . PTBP1 knockdown in renal cell carcinoma inhibits cell migration, invasion and angiogenesis in vitro and metastasis in vivo via the hypoxia inducible factor-1α pathway . Int J Oncol , 2018 . 52 ( 5 ): 1613 - 1622 . 29512730 DOI: 10.3892/ijo.2018.4296 http://doi.org/10.3892/ijo.2018.4296 . PTBP1 knockdown in renal cell carcinoma inhibits cell migration, invasion and angiogenesis in vitro and metastasis in vivo via the hypoxia inducible factor-1α pathway SH Shan , JY Shi , P Yang , 等 . Apigenin restrains colon cancer cell proliferation via targeted blocking of pyruvate kinase M2-dependent glycolysis . J Agric Food Chem , 2017 . 65 ( 37 ): 8136 - 8144 . 28829588 DOI: 10.1021/acs.jafc.7b02757 http://doi.org/10.1021/acs.jafc.7b02757 . Apigenin restrains colon cancer cell proliferation via targeted blocking of pyruvate kinase M2-dependent glycolysis S Sharma , C Maris , FHT Allain , 等 . U1 snRNA directly interacts with polypyrimidine tract-binding protein during splicing repression . Mol Cell , 2011 . 41 ( 5 ): 579 - 588 . 21362553 DOI: 10.1016/j.molcel.2011.02.012 http://doi.org/10.1016/j.molcel.2011.02.012 . U1 snRNA directly interacts with polypyrimidine tract-binding protein during splicing repression Y Shi , N Liu , WW Lai , 等 . Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells . Cancer Lett , 2018 . 422 81 - 93 . 29477380 DOI: 10.1016/j.canlet.2018.02.028 http://doi.org/10.1016/j.canlet.2018.02.028 . Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells H Shinohara , M Kumazaki , Y Minami , 等 . Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells . Cancer Lett , 2016 . 371 ( 1 ): 1 - 11 . 26607903 DOI: 10.1016/j.canlet.2015.11.020 http://doi.org/10.1016/j.canlet.2015.11.020 . Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells P Smith , A al Hashimi , J Girard , 等 . In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs . J Neurochem , 2011 . 116 ( 2 ): 240 - 247 . 21062284 DOI: 10.1111/j.1471-4159.2010.07097.x http://doi.org/10.1111/j.1471-4159.2010.07097.x . In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs C Stork , ZL Li , L Lin , 等 . Developmental Xist induction is mediated by enhanced splicing . Nucleic Acids Res , 2018 . 47 ( 3 ): 1532 - 1543 . DOI: 10.1093/nar/gky1198 http://doi.org/10.1093/nar/gky1198 . Developmental Xist induction is mediated by enhanced splicing N Sugito , K Taniguchi , Y Kuranaga , 等 . Cancer-specific energy metabolism in rhabdomyosarcoma cells is regulated by microRNA . Nucleic Acid Ther , 2017 . 27 ( 6 ): 365 - 377 . 28981396 DOI: 10.1089/nat.2017.0673 http://doi.org/10.1089/nat.2017.0673 . Cancer-specific energy metabolism in rhabdomyosarcoma cells is regulated by microRNA T Sugiyama , K Taniguchi , N Matsuhashi , 等 . MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1 . Cancer Sci , 2016 . 107 ( 12 ): 1767 - 1775 . 27696637 DOI: 10.1111/cas.13091 http://doi.org/10.1111/cas.13091 . MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1 A Sveen , S Kilpinen , A Ruusulehto , 等 . Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes . Oncogene , 2016 . 35 ( 19 ): 2413 - 2427 . 26300000 DOI: 10.1038/onc.2015.318 http://doi.org/10.1038/onc.2015.318 . Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes IA Swinburne , CA Meyer , XS Liu , 等 . Genomic localization of RNA binding proteins reveals links between pre-mRNA processing and transcription . Genome Res , 2006 . 16 ( 7 ): 912 - 921 . 16769980 DOI: 10.1101/gr.5211806 http://doi.org/10.1101/gr.5211806 . Genomic localization of RNA binding proteins reveals links between pre-mRNA processing and transcription H Takahashi , J Nishimura , Y Kagawa , 等 . Significance of polypyrimidine tract-binding protein 1 expression in colorectal cancer . Mol Cancer Ther , 2015 . 14 ( 7 ): 1705 - 1716 . 25904505 DOI: 10.1158/1535-7163.mct-14-0142 http://doi.org/10.1158/1535-7163.mct-14-0142 . Significance of polypyrimidine tract-binding protein 1 expression in colorectal cancer T Takai , Y Yoshikawa , T Inamoto , 等 . A novel combination RNAi toward Warburg effect by replacement with miR-145 and silencing of PTBP1 induces apoptotic cell death in bladder cancer cells . Int J Mol Sci , 2017 . 18 ( 1 ): 179 DOI: 10.3390/ijms18010179 http://doi.org/10.3390/ijms18010179 . A novel combination RNAi toward Warburg effect by replacement with miR-145 and silencing of PTBP1 induces apoptotic cell death in bladder cancer cells SJ Tang , SF Luo , JXJ Ho , 等 . Characterization of the regulation of CD46 RNA alternative splicing . J Biol Chem , 2016 . 291 ( 27 ): 14311 - 14323 . 27226545 DOI: 10.1074/jbc.M115.710350 http://doi.org/10.1074/jbc.M115.710350 . Characterization of the regulation of CD46 RNA alternative splicing ZZ Tang , S Sharma , S Zheng , 等 . Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein . J Biol Chem , 2011 . 286 ( 12 ): 10007 - 10016 . 21282112 DOI: 10.1074/jbc.M110.208116 http://doi.org/10.1074/jbc.M110.208116 . Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein K Taniguchi , N Sugito , M Kumazaki , 等 . Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells . Biochim Biophys Acta Mol Basis Dis , 2015 . 1852 ( 9 ): 1971 - 1980 . DOI: 10.1016/j.bbadis.2015.06.022 http://doi.org/10.1016/j.bbadis.2015.06.022 . Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells K Taniguchi , M Sakai , N Sugito , 等 . PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors . Oncotarget , 2016 . 7 ( 14 ): 18940 - 18952 . 26980745 . PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors K Taniguchi , N Sugito , H Shinohara , 等 . Organ-specific microRNAs ( MIR122 , 137 , and 206 ) contribute to tissue characteristics and carcinogenesis by regulating pyruvate kinase M1/2 ( PKM ) expression . Int J Mol Sci , 2018 . 19 ( 5 ): 1276 DOI: 10.3390/ijms19051276 http://doi.org/10.3390/ijms19051276 . Organ-specific microRNAs (MIR122, 137, and 206) contribute to tissue characteristics and carcinogenesis by regulating pyruvate kinase M1/2 (PKM) expression J Vaquero-Garcia , A Barrera , MR Gazzara , 等 . A new view of transcriptome complexity and regulation through the lens of local splicing variations . Elife, 5:e11752 , 2016 . DOI: 10.7554/eLife.11752 http://doi.org/10.7554/eLife.11752 . A new view of transcriptome complexity and regulation through the lens of local splicing variations JK Vuong , CH Lin , M Zhang , 等 . PTBP1 and PTBP2 serve both specific and redundant functions in neuronal pre-mRNA splicing . Cell Rep , 2016 . 17 ( 10 ): 2766 - 2775 . 27926877 DOI: 10.1016/j.celrep.2016.11.034 http://doi.org/10.1016/j.celrep.2016.11.034 . PTBP1 and PTBP2 serve both specific and redundant functions in neuronal pre-mRNA splicing EJ Wagner , RP Carstens , MA Garcia-Blanco . A novel isoform ratio switch of the polypyrimidine tract binding protein . Electrophoresis , 1999 . 20 ( 4-5 ): 1082 - 1086 . 10344288 . A novel isoform ratio switch of the polypyrimidine tract binding protein JL Wang , MY Yang , S Xiao , 等 . Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling . J Exp Clin Cancer Res , 2018 . 37 ( 1 ): 45 29506567 DOI: 10.1186/s13046-018-0720-8 http://doi.org/10.1186/s13046-018-0720-8 . Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling L Wang , LY Yang , ZL Yang , 等 . Glycolytic enzyme PKM2 mediates autophagic activation to promote cell survival in NPM1-mutated leukemia . Int J Biol Sci , 2019 . 15 ( 4 ): 882 - 894 . 30906218 DOI: 10.7150/ijbs.30290 http://doi.org/10.7150/ijbs.30290 . Glycolytic enzyme PKM2 mediates autophagic activation to promote cell survival in NPM1-mutated leukemia ZN Wang , D Liu , B Yin , 等 . High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin . Oncotarget , 2017 . 8 ( 22 ): 36185 - 36202 . 28404950 . High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin MC Wollerton , C Gooding , EJ Wagner , 等 . Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay . Mol Cell , 2004 . 13 ( 1 ): 91 - 100 . 14731397 DOI: 10.1016/S1097-2765(03)00502-1 http://doi.org/10.1016/S1097-2765(03)00502-1 . Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay R Xie , X Chen , Z Chen , 等 . Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM . Cancer Lett , 2019 . 449 31 - 44 . 30742945 DOI: 10.1016/j.canlet.2019.01.041 http://doi.org/10.1016/j.canlet.2019.01.041 . Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM J Xu , H Liu , Y Yang , 等 . Genome-wide profiling of cervical RNA-binding proteins identifies human papillomavirus regulation of RNASEH2A expression by viral E7 and E2F1 . mBio , 2019 . 10 ( 1 ): e02687 - 18 . 30696738 DOI: 10.1128/mBio.02687-18 http://doi.org/10.1128/mBio.02687-18 . Genome-wide profiling of cervical RNA-binding proteins identifies human papillomavirus regulation of RNASEH2A expression by viral E7 and E2F1 YC Xue , Y Zhou , TB Wu , 等 . Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping . Mol Cell , 2009 . 36 ( 6 ): 996 - 1006 . 20064465 DOI: 10.1016/j.molcel.2009.12.003 http://doi.org/10.1016/j.molcel.2009.12.003 . Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping B Yang , PS Hu , XH Lin , 等 . PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas . Cell Mol Life Sci , 2015 . 72 ( 22 ): 4383 - 4397 . 26047657 DOI: 10.1007/s00018-015-1938-7 http://doi.org/10.1007/s00018-015-1938-7 . PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas Y Yang , CF Wang , KL Zhao , 等 . TRMP, a p53-inducible long noncoding RNA, regulates G1/S cell cycle progression by modulating IRES-dependent p27 translation . Cell Death Dis , 2018 . 9 ( 9 ): 886 30166522 DOI: 10.1038/s41419-018-0884-3 http://doi.org/10.1038/s41419-018-0884-3 . TRMP, a p53-inducible long noncoding RNA, regulates G1/S cell cycle progression by modulating IRES-dependent p27 translation WL Yao , P Yue , GJ Zhang , 等 . Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/AKT signaling in human lung cancer cells . Cancer Lett , 2015 . 364 ( 1 ): 70 - 78 . 25937299 DOI: 10.1016/j.canlet.2015.04.028 http://doi.org/10.1016/j.canlet.2015.04.028 . Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/AKT signaling in human lung cancer cells K Yap , ZQ Lim , P Khandelia , 等 . Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention . Genes Dev , 2012 . 26 ( 11 ): 1209 - 1223 . 22661231 DOI: 10.1101/gad.188037.112 http://doi.org/10.1101/gad.188037.112 . Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention L Zhang , Z Yang , J Trottier , 等 . Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay . Hepatology , 2017 . 65 ( 2 ): 604 - 615 . 27770549 DOI: 10.1002/hep.28882 http://doi.org/10.1002/hep.28882 . Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay SL Zhang , JS Wei , SQ Li , 等 . MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma . Cancer Lett , 2016 . 371 ( 2 ): 214 - 224 . 26683771 DOI: 10.1016/j.canlet.2015.11.045 http://doi.org/10.1016/j.canlet.2015.11.045 . MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma T Zhang , JJ Li , Y He , 等 . A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer . Nat Commun , 2018 . 9 ( 1 ): 3726 30213946 DOI: 10.1038/s41467-018-06179-0 http://doi.org/10.1038/s41467-018-06179-0 . A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer XC Zhang , MH Chen , XB Wu , 等 . Cell-type-specific alternative splicing governs cell fate in the developing cerebral cortex . Cell , 2016 . 166 ( 5 ): 1147 - 1162e15 . 27565344 DOI: 10.1016/j.cell.2016.07.025 http://doi.org/10.1016/j.cell.2016.07.025 . Cell-type-specific alternative splicing governs cell fate in the developing cerebral cortex M Zhao , ML Zhuo , X Zheng , 等 . FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells . Oncotarget , 2019 . 10 ( 1 ): 30 - 44 . 30713601 . FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells SK Zheng , EE Gray , G Chawla , 等 . PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2 . Nat Neurosci , 2012 . 15 ( 3 ): 381 - 388 . 22246437 DOI: 10.1038/nn.3026 http://doi.org/10.1038/nn.3026 . PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2 C Zhou , YL Wu , G Chen , 等 . Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study . Lancet Oncol , 2011 . 12 ( 8 ): 735 - 742 . 21783417 DOI: 10.1016/s1470-2045(11)70184-x http://doi.org/10.1016/s1470-2045(11)70184-x . Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study Compliance with ethics guidelines Wei ZHU, Bo-lun ZHOU, Li-juan RONG, Li YE, Hong-juan XU, Yao ZHOU, Xue-jun YAN, Wei-dong LIU, Bin ZHU, Lei WANG, Xing-jun JIANG, and Cai-ping REN declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors. 10.1631/jzus.B1900422 Project supported by the National Natural Science Foundation of China (Nos. 81773179, 81272972, and 81472355), the Program for New Century Excellent Talents in University (No. NCET-10-0790), the Hunan Provincial Science and Technology Department (Nos. 2016JC 2049 and 2014FJ6006), the Hunan Provincial Natural Science Foundation of China (No. 2016JJ2172), and the Undergraduate Training Programs for Innovation and Entrepreneurship (Nos. 201810533368, GS201910533474, and GS201910533236), China 2019-07-16 2019-10-21 2022-01-05 Copyright © Zhejiang University and Springer-Verlag GmbH Germany, part of Springer Nature 2020 2020 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 02 21